[Effect of neuroautonomic block and sodium hydroxybutyrate on brain metabolism during the early stages of severe experimental craniocerebral injuries].
D000208:Acute Disease; D000818:Animals; D001921:Brain / Q000378:metabolism*; D001930:Brain Injuries / Q000378:metabolism / Q000628:therapy*; D002415:Cats; D002746:Chlorpromazine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004734:Energy Metabolism; D006885:Hydroxybutyrates / Q000008:administration & dosage*; D008614:Meperidine / Q000031:analogs & derivatives*; D011396:Promedol / Q000008:administration & dosage*; D011398:Promethazine / Q000008:administration & dosage*; D012886:Skull / Q000293:injuries; D012978:Sodium Oxybate / Q000008:administration & dosage*
D006885:Hydroxybutyrates; D011396:Promedol; D012978:Sodium Oxybate; D008614:Meperidine; D011398:Promethazine; D002746:Chlorpromazine
Vliianie neĭrovegetativnoĭ blokady i oksibutirata natriia na metabolizm golovnogo mozga v rannem periode tiazheloĭ cherepno-mozgovoĭ travmy (v éksperimente).